UNSPSC 41181523: Factor xiii, a, s, immunological test system

In this classification, a Factor xiii, a, s, immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Factor xiii, a, s,. US FDA regulates Factor xiii, a, s, immunological test system under 21 CFR 866.5330 and under FDA product code DBT.

UNSPSC 41181523 Factor XIII, A, S, Immunological Test System is a Commodity code that does not reflect the scope of recent state and local procurement activity posted under this designation. The code nominally describes immunological testing systems for blood coagulation factor analysis; however, the recent opportunities tagged with this code span unrelated equipment and services, including optical surface profilers, airfield lighting photometric testing, laboratory software licenses, electrical meter test boards, high-voltage capacitance measurement modules, brake testers, water quality analyzers, transformer oil testing services, atmospheric monitoring sensors, and landscape architectural design. None of these procurements involve factor XIII testing or immunological assays. The mismatch suggests either tagging errors in the source systems or a code misclassification that renders this UNSPSC designation unhelpful for forecasting actual demand in factor XIII immunological testing equipment or services.

State and local procurement activity under this code shows no relevant recent opportunities. The opportunities posted do reflect activity across multiple issuing bodies—higher education institutions (Valencia College, Jackson State University, Texas State University, Texas A&M University System), municipal utilities (City of Ocala Electric Utility, City of Phoenix Water Services, Lubbock Power & Light, City of Tampa), transit and port authorities (Lee County Port Authority, Kissimmee Utility Authority, Colorado State Patrol), counties (Marion County Oregon, Collier County Florida), and state health agencies (Texas HHSC/DSHS)—but their scope diverges materially from the code's nominal definition. Without recent opportunities genuinely soliciting factor XIII immunological test systems under this code, the activity level and buyer concentration cannot be assessed.